Askgene Pharma, Inc.

This large Phase 3 trial is testing whether adding a new drug called ASKB589 to standard chemotherapy and immunotherapy works better for advanced stomach or gastroesophageal cancer. The study is for patients whose cancer tests positive for a specific protein called CLDN18.2 and w…

This early-stage study is testing the safety and effects of a new drug called ASKG712, given as an injection into the eye, for people with diabetic macular edema (DME). DME is a swelling in the back of the eye that can cause vision loss in people with diabetes. The main goal is t…

This is the first study in people testing a new drug called ASKG712, given as an injection into the eye, for wet age-related macular degeneration (AMD). The main goal is to find out if different doses are safe and how the body processes the drug. Researchers will also check if th…

This study is testing a new drug called ASKB589, given alongside standard chemotherapy and immunotherapy, for people with advanced stomach or gastroesophageal junction cancer. The main goals are to find a safe dose and see how well the body handles the drug combination. Researche…